Familial amyloid polyneuropathy (FAP) is rare and most commonly caused by the Val30Met mutation of the transthyretin (TTR) gene. Beside polyneuropathy, other complications due to amyloid deposits occur, but may vary in phenotype. The mutation tends to occur in endemic clusters.We describe a 65-year-old man from a non-endemic FAPVal30Met area who developed a progressive generalized painless axonal sensorimotor polyneuropathy with mild autonomic involvement and absent FAP symptoms in the family. Nerve biopsy showed amyloid deposits, staining withTTR-antibodies on immunohistochemistry.After DNA-sequencing of theTTR gene, the diagnosis of FAP Val30Met was made. Late-onset FAP Val30Met is a progressive and fatal disorder with varying penetrance,...
International audienceObjective To compare the natural history of familial transthyretin amyloid pol...
International audienceObjective To compare the natural history of familial transthyretin amyloid pol...
International audienceObjective To compare the natural history of familial transthyretin amyloid pol...
Familial amyloid polyneuropathy (FAP) is rare and most commonly caused by the Val30Met mutation of t...
Introduction: Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) typically arises as an...
Familial amyloid polyneuropathy (FAP) is a rare condition caused by mutations of the transthyretin (...
International audienceTransthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal domin...
International audienceTransthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal domin...
International audienceTransthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal domin...
We herein report the case of an 84-year-old woman with transthyretin (TTR) Val30Met-associated famil...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
Introduction: Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) typically arises as an...
International audienceObjective To compare the natural history of familial transthyretin amyloid pol...
International audienceObjective To compare the natural history of familial transthyretin amyloid pol...
International audienceObjective To compare the natural history of familial transthyretin amyloid pol...
Familial amyloid polyneuropathy (FAP) is rare and most commonly caused by the Val30Met mutation of t...
Introduction: Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) typically arises as an...
Familial amyloid polyneuropathy (FAP) is a rare condition caused by mutations of the transthyretin (...
International audienceTransthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal domin...
International audienceTransthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal domin...
International audienceTransthyretin familial amyloid polyneuropathies (TTR-FAPs) are autosomal domin...
We herein report the case of an 84-year-old woman with transthyretin (TTR) Val30Met-associated famil...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
Familial amyloid polyneuropathy (FAP) is a progressive systemic autosomal dominant disease caused by...
Introduction: Transthyretin-related familial amyloid polyneuropathy (TTR-FAP) typically arises as an...
International audienceObjective To compare the natural history of familial transthyretin amyloid pol...
International audienceObjective To compare the natural history of familial transthyretin amyloid pol...
International audienceObjective To compare the natural history of familial transthyretin amyloid pol...